Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

OXURION to Present at the Lytham Partners Fall 2021 Investor Conference

5 Oct 2021

Leuven, BELGIUM, Boston, MA, US – 5 October, 2021 – 08.00 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will present at the Lytham Partners Fall 2021 Investor Conference.

  • Lytham Partners Fall 2021 Investor Conference

October 5-7, 2021

Pre-recorded CEO Presentation available starting on October 5 at 10:15 AM ET

 

For more information, please visit Oxurion’s events page.